| Margins | Mean rates for WC secured loans at 8.56%-8.81%. |
|---|---|
| Management confidence | Neutral; data-driven disclosure of interest rate ranges. |
Growth
Interest rates for business loans averaged 18.9%, significantly higher than secured working capital products.
Outlook
Jan-Mar 2026 data shows secured working capital rates stabilizing between 7.5% and 14.25%.
Risks
Wide variance in business loan rates (9.5% to 25%) indicates high-risk borrower profiles.
Earnings Call filed with NSE, NSE: AXISBANK. Summary written with AI assistance from the document.
Axis Bank Ltd: key numbers
- Share price
- ₹1,331.00
- Market cap
- ₹4,14,537 Cr
- Revenue (annual)
- ₹1,32,538 Cr
- Net profit (annual)
- ₹26,385 Cr
- P/E (TTM)
- 13.8×Sector 21.0×
- Promoter holding
- 7.86%-0.01% QoQ
- FII holding
- 38.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Axis Bank Ltd
All →Axis Bank Other Announcement
Axis Bank disclosed a connected person's sale of 2,000 shares worth about Rs.0.27 Crore on 11 November 2026. The sale left the holder with nil shares.
- Value
- ₹0.27 Cr
Axis Bank Employee Stock Options
Axis Bank allotted 220,144 equity shares on November 11, 2026, under its ESOP/RSU scheme. The paid-up capital increased, with no cash value stated for the allotment.
Axis Bank Annual General Meeting
Axis Bank's postal ballot passed four resolutions, re-appointing two directors and appointing two others. The scrutinizer's report and voting results were filed on 6 November 2026.
Axis Bank Management Change
Axis Bank disclosed that Independent Director Girish Paranjpe ceased to be a director on completion of his tenure, effective close of business on 1 November 2026. No monetary value is involved in this change.
Axis Bank Employee Stock Options
Axis Bank granted 1,05,460 stock options at Rs.1,217 each under its ESOS 2000-01. Options vest over three years, exercisable within five years of vesting.
Axis Bank Legal & Regulatory
Axis Bank disclosed a SEBI censure order against subsidiary Axis Capital Limited. No investor harm or fraudulent design was involved.